CDH1 and breast cancer: Together, these results establish Id2 as a novel and p120-responsive transcriptional Kaiso target on its canonical target site and provide a mechanistic rationale for the Id2-dependent pro-metastatic control over anoikis resistance in E-cadherin mutant breast cancer cells.